Bologna, Italy

Gabriella Campadelli

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Alma Mater Studiorum-Universitá Di Bologna. Active years: 2015-2017.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gabriella Campadelli: Innovator in Herpes Simplex Virus Research

Introduction

Gabriella Campadelli is a prominent inventor based in Bologna, Italy. She has made significant contributions to the field of virology, particularly in the study and modification of the Herpes Simplex Virus (HSV). With a total of 2 patents, her work has the potential to impact therapeutic approaches to viral infections.

Latest Patents

Gabriella's latest patents focus on a modified Herpes Simplex Virus (HSV) with altered tropism. The first patent describes a modified HSV that has a portion of glycoprotein D (gD) of the glycoproteic envelope deleted. In place of this deleted portion, a heterologous single chain antibody is inserted. This modification allows the HSV to infect cells through the HER2/ErbB2 receptor while avoiding infection through the HVEM/HveA and nectin1/HveC receptors. The patent also discloses the uses of this modified HSV and the process of its preparation.

Career Highlights

Gabriella Campadelli is affiliated with Alma Mater Studiorum - Università di Bologna, where she conducts her research. Her work has garnered attention in the scientific community, contributing to advancements in understanding viral mechanisms and potential treatments.

Collaborations

One of her notable collaborators is Laura Menotti, who works alongside Gabriella in her research endeavors. Their partnership exemplifies the collaborative spirit in scientific research, enhancing the potential for innovative discoveries.

Conclusion

Gabriella Campadelli's contributions to the field of virology, particularly through her innovative patents on modified Herpes Simplex Virus, highlight her role as a leading inventor in this area. Her work continues to pave the way for new therapeutic strategies against viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…